194 related articles for article (PubMed ID: 10928955)
21. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
22. A novel thromboxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation.
Agrawal DK; Takami M; Ono S
Inflammation; 1997 Feb; 21(1):1-8. PubMed ID: 9179617
[TBL] [Abstract][Full Text] [Related]
23. Effects of human lung fibroblasts on eosinophil degranulation.
Takafuji S; Miyakuni Y; Nakagawa T; Shoji S; Murata S; Yamamoto K; Ito K
Allergy; 2000 Dec; 55(12):1170-8. PubMed ID: 11117275
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations.
Zeck-Kapp G; Kroegel C; Riede UN; Kapp A
Allergy; 1995 Jan; 50(1):34-47. PubMed ID: 7741187
[TBL] [Abstract][Full Text] [Related]
25. A microtiter assay for activation of eosinophils. Simultaneous monitoring of eosinophil adhesion and degranulation.
Reimert CM; Skov PS; Poulsen LK
Allergy; 1998 Feb; 53(2):129-38. PubMed ID: 9534910
[TBL] [Abstract][Full Text] [Related]
26. Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils.
Thomet OA; Wiesmann UN; Blaser K; Simon HU
Clin Exp Allergy; 2001 Aug; 31(8):1310-20. PubMed ID: 11529903
[TBL] [Abstract][Full Text] [Related]
27. [Eosinophil granule proteins (MBP, ECP, EPX/EDN, EPO)--a possible process of eosinophil activation and degranulation].
Tsuda S; Miyasato M
Nihon Rinsho; 1993 Mar; 51(3):613-9. PubMed ID: 8492433
[TBL] [Abstract][Full Text] [Related]
28. Intercellular adhesion molecule-1 on eosinophils is involved in eosinophil protein X release induced by cytokines.
Horie S; Okubo Y; Hossain M; Momose T; Suzuki J; Isobe M; Sekiguchi M
Immunology; 1997 Feb; 90(2):301-7. PubMed ID: 9135561
[TBL] [Abstract][Full Text] [Related]
29. Effects of PAF, FMLP and opsonized zymosan on the release of ECP, elastase and superoxide from human granulocytes.
Turner NC; Wood LJ; Foster M; Gueremy T
Eur Respir J; 1994 May; 7(5):934-40. PubMed ID: 8050551
[TBL] [Abstract][Full Text] [Related]
30. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.
Tohma S; Hirohata S; Lipsky PE
J Immunol; 1991 Jan; 146(2):492-9. PubMed ID: 1670945
[TBL] [Abstract][Full Text] [Related]
31. [Eosinophils in immediate allergic reactions].
Takizawa H
Nihon Rinsho; 1993 Mar; 51(3):664-8. PubMed ID: 8388063
[TBL] [Abstract][Full Text] [Related]
32. Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration.
Ebisawa M; Bochner BS; Georas SN; Schleimer RP
J Immunol; 1992 Dec; 149(12):4021-8. PubMed ID: 1460288
[TBL] [Abstract][Full Text] [Related]
33. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
Tamura N; Agrawal DK; Townley RG
J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation.
Eda R; Sugiyama H; Hopp RJ; Okada C; Bewtra AK; Townley RG
Int Arch Allergy Immunol; 1993; 102(4):391-8. PubMed ID: 8241801
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of azelastine hydrochloride on Ca2+ influx, actin polymerization and release of eosinophil cationic protein of an eosinophilic leukaemia cell line EoL-1.
Morita M; Ohshima Y; Akutagawa H; Uenoyama Y; Nambu M; Mayumi M; Mikawa H
Curr Med Res Opin; 1993; 13(3):163-74. PubMed ID: 8222744
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of eosinophil activation in bronchoalveolar lavage fluid from atopic asthmatics by Y-24180, an antagonist to platelet-activating factor.
Mizuki M; Komatsu H; Akiyama Y; Iwane S; Tsuda T
Life Sci; 1999; 65(20):2031-9. PubMed ID: 10579457
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of cloned human T lymphocytes via the CD3 or CD28 molecules induces enhancement in vascular endothelial permeability to macromolecules with participation of type-1 and type-2 intercellular adhesion pathways.
Damle NK; Doyle LV
Eur J Immunol; 1990 Sep; 20(9):1995-2003. PubMed ID: 1698638
[TBL] [Abstract][Full Text] [Related]
38. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
Slifman NR; Loegering DA; McKean DJ; Gleich GJ
J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
[TBL] [Abstract][Full Text] [Related]
39. Study of eosinophil-endothelial adhesion, production of oxygen radicals and release of eosinophil cationic protein by peripheral blood eosinophils of patients with rheumatoid arthritis.
Mertens AV; De Clerck LS; Moens MM; Bridts CH; Stevens WJ
Clin Exp Allergy; 1993 Oct; 23(10):868-73. PubMed ID: 10780895
[TBL] [Abstract][Full Text] [Related]
40. [Basic research into the measurement of eosinophil cationic protein (ECP) in blood samples].
Kurihara K; Yamada T; Saito H; Iikura Y
Arerugi; 1992 Apr; 41(4):512-8. PubMed ID: 1622334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
